The Polycomb proteins RING1B and EZH2 repress the tumoral pro-inflammatory function in metastasizing primary cutaneous squamous cell carcinoma
Open Access
- 31 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 39 (3) , 503-513
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy in humans and approximately 5% metastasize, usually to regional lymph nodes. Epigenetic regulation of gene expression may allow tumoral cells to acquire new functions in order to escape from the primary tumor. The aim of this study was to investigate the expression and function of proteins of the Polycomb family of epigenetic regulators in the metastatic process of cSCC. A higher expression of RING1B and EZH2 was detected by immunohistochemistry in a series of primary cSCC tumors that metastasized (MSCCs) when compared with non-metastasizing cSCCs (non-MSCCs). Stable downregulation of RING1B and EZH2 in cSCC cells results in enhanced expression of inflammatory cytokines and activation of the NF-κB signaling pathway. Accordingly, non-MSCCs display higher levels of membranous pS176-inhibitor of NF-kB kinase, and their stroma is enriched in neutrophils and eosinophils when compared with MSCCs. In vitro, hematopoietic cells exhibit a substantial migratory response to supernatants from Polycomb-depleted cSCC cells. Altogether, these data indicate that RING1B and EZH2 repress the innate inflammatory cSCC function and impair tumor immunosurveillance and suggest that patients with high-risk cSCCs could benefit from clinical therapies addressed to harness the immune response.Keywords
Funding Information
- Fondo de Investigación Sanitaria (PS09/00973, PI15/00236)
- Instituto de Salud Carlos III
- Ministerio de Economía y Competitividad
This publication has 43 references indexed in Scilit:
- EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLDInternational Journal of Molecular Sciences, 2013
- Chromatin targeting drugs in cancer and immunityGenes & Development, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- The histone H3K27 methylation mark regulates intestinal epithelial cell density‐dependent proliferation and the inflammatory responseJournal of Cellular Biochemistry, 2012
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family ComplexesMolecular Cell, 2012
- Non-canonical NF-κB signaling pathwayCell Research, 2010
- Epithelial decision makers: in search of the 'epimmunome'Nature Immunology, 2010
- Skin immune sentinels in health and diseaseNature Reviews Immunology, 2009
- The Polycomb Protein and E3 Ubiquitin Ligase Ring1B Harbors an IRES in its Highly Conserved 5′ UTRPLOS ONE, 2008
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005